Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) EBT Margin (2016 - 2026)

Cumberland Pharmaceuticals' EBT Margin history spans 16 years, with the latest figure at 10.18% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 859.0% to 10.18% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.31%, a 1076.0% increase, with the full-year FY2025 number at 6.31%, up 1076.0% from a year prior.
  • EBT Margin hit 10.18% in Q4 2025 for Cumberland Pharmaceuticals, up from 23.44% in the prior quarter.
  • Over the last five years, EBT Margin for CPIX hit a ceiling of 10.7% in Q1 2025 and a floor of 67.11% in Q4 2023.
  • Historically, EBT Margin has averaged 14.46% across 5 years, with a median of 11.78% in 2024.
  • Biggest five-year swings in EBT Margin: tumbled -4068bps in 2023 and later soared 4834bps in 2024.
  • Tracing CPIX's EBT Margin over 5 years: stood at 52.59% in 2021, then skyrocketed by 50bps to 26.43% in 2022, then plummeted by -154bps to 67.11% in 2023, then soared by 72bps to 18.77% in 2024, then surged by 46bps to 10.18% in 2025.
  • Business Quant data shows EBT Margin for CPIX at 10.18% in Q4 2025, 23.44% in Q3 2025, and 6.73% in Q2 2025.